The Impact of COVID-19 in Cystic Fibrosis
Xiaohong Xia
- Vol. 58, Iss: 6, pp 466-468
About:
The article was published on 2022-06-01 and is currently open access. It has received 6 citations till now. The article focuses on the topics: Medicine & Cystic fibrosis.read more
Citations
More filters
Journal ArticleDOI
Short and Long-Term Impact of COVID-19 Infection on Previous Respiratory Diseases
Eusebi Chiner-Vives,R. Cordovilla-Pérez,D. de la Rosa-Carrillo,Marta García-Clemente,José Luis Izquierdo-Alonso,Remedios Otero-Candelera,Luis Pérez de Llano,Jacobo Sellares-Torres,José Ignacio de Granda-Orive +8 more
TL;DR: In this article , the authors provided information on the impact of the COVID-19 disease on pre-existing lung comorbidities, such as asthma, chronic obstructive pulmonary disease (COPD), interstitial lung disease, etc.
Journal ArticleDOI
Real‐life efficacy and safety of elexacaftor/tezacaftor/ivacaftor on severe cystic fibrosis lung disease patients
Renate Kos,Anne H. Neerincx,Dominic William Fenn,Paul Brinkman,Rianne Lub,Steffie E. M. Vonk,Jolt Roukema,M. H. E. Reijers,S. W. J. Terheggen-Lagro,Josje Altenburg,Christof J. Majoor,Lieuwe D. J. Bos,Eric G. Haarman,Anke-Hilse Maitland-van der Zee +13 more
TL;DR: In this paper , a multicenter longitudinal observational study was conducted to examine changes in FEV1, BMI, and adverse events at initiation and 1, 3, 6, and 12 months after ETI treatment.
Journal ArticleDOI
SARS-CoV-2 Infection in Patients with Cystic Fibrosis: What We Know So Far
TL;DR: In this paper , the authors summarize and discuss recent advances in understanding the susceptibility of CF individuals to SARS-CoV-2 infection and conclude that the best protection for these patients is to strengthen preventive measures, such as social distancing and the use of masks.
Journal ArticleDOI
Impact of COVID-19 pandemic on health care system, work, and mental well-being of people with cystic fibrosis
TL;DR: A cross-sectional online survey was developed by the Cystic fibrosis (CF) Ireland research team and uploaded on SmartSurvey UK as discussed by the authors , which aims to examine impact of COVID-19 pandemic on the lives of CF patients in relation to hospital visits, use of telemedicine, employment, and mental well-being.
Journal ArticleDOI
Is There a Difference in Immune Response to SARS-CoV-2 Vaccination between Liver and Lung Transplant Patients with Cystic Fibrosis?
TL;DR: In this article , the authors assessed antibody response of patients with CF who have undergone liver (CF-LI) or lung transplantation, and compared results to patients with solid organ transplantation without CF as underlying disease.
References
More filters
Journal ArticleDOI
Impact of COVID-19 on people with cystic fibrosis.
Carla Colombo,Pierre-Régis Burgel,Silvia Gartner,Silke van Koningsbruggen-Rietschel,Lutz Naehrlich,Isabelle Sermet-Gaudelus,Kevin W Southern +6 more
Journal ArticleDOI
A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis.
Rebecca Cosgriff,Susannah Ahern,Scott C. Bell,Keith G. Brownlee,Pierre-Régis Burgel,Cass Byrnes,Harriet Corvol,Stephanie Y. Cheng,Alexander Elbert,Albert Faro,Christopher H. Goss,Vincent Gulmans,Bruce C. Marshall,Edward F. McKone,Peter G. Middleton,Rasa Ruseckaite,Anne L. Stephenson,Anne L. Stephenson,Siobhán B. Carr +18 more
TL;DR: This early report shows good recovery from SARS-CoV-2 in this heterogeneous CF cohort, but the current numbers are too small to draw firm conclusions and people with CF should continue to strictly follow public health advice to protect themselves from infection.
Journal ArticleDOI
Incidence and clinical impact of respiratory viruses in adults with cystic fibrosis
William G Flight,William G Flight,Rowland J. Bright-Thomas,Rowland J. Bright-Thomas,Peter Tilston,K.J. Mutton,K.J. Mutton,Malcolm Guiver,Julie Morris,A. Kevin Webb,A. Kevin Webb,Andrew Jones,Andrew Jones +12 more
TL;DR: VRI is common in adults with CF and is associated with substantial morbidity and Respiratory viruses are a potential therapeutic target in CF lung disease.
Journal ArticleDOI
The global impact of SARS-CoV-2 in 181 people with cystic fibrosis.
Elliot McClenaghan,Rebecca Cosgriff,Keith G. Brownlee,Susannah Ahern,Pierre-Régis Burgel,Catherine A. Byrnes,Carla Colombo,Harriet Corvol,Stephanie Y. Cheng,Géraldine Daneau,Alexander Elbert,Albert Faro,Christopher H. Goss,Vincent Gulmans,Hector H. Gutierrez,Isabelle de Monestrol,Andreas Jung,Lutz Nährlich Justus,Nataliya Kashirskaya,Bruce C. Marshall,Edward F. McKone,Peter G. Middleton,Pedro Mondejar-Lopez,M. Dolores Pastor-Vivero,Rita Padoan,Samar Rizvi,Rasa Ruseckaite,Marco Salvatore,Anne L. Stephenson,Anne L. Stephenson,Luiz Vicente R.da Silva Filho,Joel Melo,Marco Zampoli,Siobhán B. Carr +33 more
TL;DR: Outcomes in this large cohort of 181 people with CF are better than initially feared overall, possibly due to a protective effect of the relatively younger age of the CF population compared to other chronic conditions, but SARS-CoV-2 is not a benign disease for all people in this patient group.
Journal ArticleDOI
Reduction in hospitalised COPD exacerbations during COVID-19: A systematic review and meta-analysis.
Jaber S Alqahtani,Jaber S Alqahtani,Tope Oyelade,Abdulelah M Aldhahir,Renata Gonçalves Mendes,Saeed M Alghamdi,Saeed M Alghamdi,Marc Miravitlles,Swapna Mandal,Swapna Mandal,John R. Hurst,John R. Hurst +11 more
TL;DR: In this article, the authors reported a 50% reduction in admissions for COPD exacerbations during the COVID-19 pandemic period compared to pre-pandemic times, likely associated with a reduction in respiratory viral infections that trigger exacerbations.
Related Papers (5)
Racing Towards the Development of Diagnostics for a Novel Coronavirus (2019-nCoV).
Y.M. Dennis Lo,Rossa W.K. Chiu +1 more